Anti-allergy medicine EpiPen recall expands to US

Posted April 02, 2017

Mylan, the maker of the EpiPen, announced Friday that Meridian Medical Technologies expanded the recall to include the United States.

They say there haven't been any confirmed cases involving lots of the injectors distributed in Canada. EpiPens affected under the new recall were distributed in the US between December 17, 2015, and July 1, 2016.

In a statement, Mylan pointed to "two previously disclosed reports" outside of the USA in which the device failed to activate due to a "potential defect" in a component supplied by Meridian Medical Technologies, a Pfizer unit that makes EpiPen.

Kentucky's freshmen upstage the Lonzo Ball show
His counterpart, Ball, settled for 10 points off 4-of-10 shooting (1-of-6 from three) with eight assists and four turnovers. He hit four of his first five shots, including a pair of 3s, within the first five minutes of the second.

The problems could be potentially life-threatening, although Mylan described the incidence of the defects as "extremely rare". The company said more than 80,000 of the life-saving auto-injectors are covered by the recall worldwide, which was prompted by two reports of device failures. This company also makes a Generic EpiPen that is not included in the recall, according to ABC 15. (0.15 mg) are sold as 2 Pak Auto-Injectors.

Mylan advised consumers to use their current EpiPens, if needed, until they receive a replacement.

This voluntary recall is being conducted with the knowledge of FDA.

You can play Ms. Pac-Man in Google Maps
For example, search "do a barrel roll" and the screen will do a 360-degree turn, in honor of the classic Nintendo series Star Fox. Obviously, playing on a mobile device within Google Maps leaves something to be desired if you're used to arcade controls.

The devices affected by the recall are EpiPens with strengths of 0.3 mg and 0.15 mg.

EpiPen (epinephrine) Auto‐Injectors are indicated for the emergency treatment of anaphylactic reactions in patients who are determined by a physician to be at increased risk for anaphylaxis.

White House invites lawmakers to see intelligence material
The New York Times reported Thursday that Ezra Cohen-Watnick and Michael Ellis were the White House officials who sourced Nunes. He added that his "smell test" remark was based on Nunes's words at the time .